Get Permission Krishna, Rao, Ahmed, and Vishwanath: A high-sensitivity C-reactive protein in assessing severity of asthma: A case control study


Introduction

Asthma is characterized with constant inflammatory disease of airway system. Persistent inflammation is related with hyper responsiveness in airway & it is an exaggerated airway-narrowing response to certain triggers, for example, allergens, infections and exercise that prompts repetitive experiences of breathlessness, wheezing, chest tightness as well as coughing that may vary over the time and in intensity. Manifestation events are connected with widespread, obstruction of floe of air inside the lungs that is normally reversible either precipitously or with proper asthma treatment, for example, an effective bronchodilator.1

Asthma is an associative with T partner cell type-2 (Th2) invulnerable reactions, which are commonplace of other atopic conditions. Asthma triggers may comprise easily affected (e.g., house dust contamination, creature dander, shape, cockroach build-up and dusts) and non-hypersensitive (e.g., viral sicknesses, cold air, tobacco smoke) boosts, which produce a course of occasions prompting ongoing aviation route aggravation. Raised degrees of Th2 cells in the aviation route framework discharge explicit cytokines, including interleukin (IL)- 4, IL-5, IL-9 and IL-13 and advance eosinophilic disturbance and immunoglobulin E (IgE) creation. IgE creation consequently triggers the arrival of incendiary go between like leukotrienes and histamine cause bronchospasm (withdrawal of the smooth muscle in the aviation routes), expanded mucous emission, edema and which lead to the trademark signs of asthma.2, 3, 4, 5

Spirometry gauges wind stream boundaries like the constrained fundamental limit (FVC, the more volume of air that can be inhaled out) and the constrained expiratory volume in 1s (FEV1). Lung volumes are not assessed with spirometry, and rather need full pneumonic capacity test. The extent of FEV1/FVC gives a proportion of wind stream check. In everyone, the FEV1/FVC extent is by and large more than 0.75–0.80 in grown-ups and 0.90 in kids. Any reaches not exactly these suggest wind current impediment and backing a finding of asthma.6, 7 Besides, the suppression of inflammation with appropriate management is connected with decrease of serum hs-CRP level.8, 9 These perceptions give a rational to serum hs-CRP to be considered as a method for findings in systemic inflammation, response to treatment just as for assessing asthma status.

Materials and Methods

This is prospective and descriptive study patients were derived among patients with asthma presented for follow -up examination in outpatient Department of Pulmonary Medicine of Government Medical College and Hospital, Nizamabad, India from October 2020 to March 2021. After approval of IEC study was initiated and patients consent were also obtained. The patients were on maintenance treatment including inhaled corticosteroids and bronchodilators according to the guideline treatment of asthma.10

All eligible patients were included except those with COPD, bronchiectasis, pulmonary infection, connective tissue diseases, vasculitis, coexistent acute or chronic localized or systemic infection or inflammatory conditions at respiratory or musculoskeletal, gastrointestinal, urinary tract and gastrointestinal systems as well as patients with malignancies and history of inflammatory disease.

The subjects of the control group were selected among the healthy personals of the same hospital that had not asthma. Similar exclusion criteria were also applied to the control group.

Diagnosis of asthma was confirmed based on clinical features and pulmonary function test. All patients received standard treatment to achieve control. The level of control of asthma was determined using ACT.

Serum CRP was measured by ELISA method according to the manufacturer’s instruction using a high sensitive CRP kit which serum levels less than 1 mg/L were considered normal.

Statistical analysis

In statistical analysis, the serum hs-CRP was compared between patients and controls Parametric and non-parametric. Mann-Whitney U tests were utilized for correlation of factors with or without typical conveyance individually. The chi square test with computation of chances proportion (OR) and 95% certainty span (95% CI) was utilized for affiliation and Spearman test was utilized for assurance of connection.

Results

In our present study, a total of 65 patients were included out of which 36 (55.3%) were males and 29 (44.6%) were females in case group (Table 1).

Table 1

Distribution of gender

Case

Control

Gender

No. of patients

Percentage

No. of patients

Percentage

Male

36

55.3

38

58.4

Female

29

44.6

27

41.5

Total

65

100

65

100

Table 2

Distribution of different age groups of patients

Case

Control

Age

No. of patients

Percentage

No. of patients

Percentage

18-30 years

3

4.6

4

6.1

31-50 years

19

29.2

17

26.1

51-70 years

36

55.4

39

60.0

>71 years

7

10.8

5

7.6

Total

65

100

65

100

In Table 2, in our study, most of the patients were 51-70 years i.e., 36 out of 65 (55.4%), followed by 31-50 years, i.e., 19 out of 65 (29.2%) in case group.

Table 3

Distribution of hsCRP of between two groups of patients

Case (n=65)

Control (n=65)

Mean ±SD

Mean ±SD

hsCRP

3.62±0.84

0.83±0.15

In Table 3, the mean hsCRP in case group patients are 3.62±0.84 and in control group patients 0.83±0.15.

Table 4

Distribution of Pulmonary lung function (FEV1) between two groups of patients

Case (n=65)

Control (n=65)

Mean ±SD

Mean ±SD

FEV1%

61.38±5.39

81.64±6.32

FVC

72.48±6.34

93.23±9.16

Table 5

Comparison of Pulmonary function and hsCRP using Spearman correlation

Case (n=65)

R

p-value

FEV1%

-0.474

0.0001

In Table 5, pulmonary function test using Spirometer was done in all the patients (case and control). The FEV1 values are compared against hsCRP values. Statistical significance is assessed using Spearmann’s correlation. Case group patients showing highly significant negative correlation of hsCRP with FEV1.

Discussion

In asthma, the meaning of aviation route framework irritation has been perceived. Other than the aviation route aggravation, fundamental irritation may likewise exist in asthma. The relevance of high affectability measures for hs-CRP, which is known to be a delicate marker of second rate foundational aggravation, has not been totally gathered in asthma. Studies have attempted to favor the usage of hs-CRP as a proxy marker of aviation route irritation in bronchial asthma. The discoveries by Raita Y et al.11 cross-sectional uncovered the serum hs-CRP levels in steroid-unsophisticated and steroid-breathing in grown-up non-smoker patients with asthma and solid controls. Late examinations have shown expanded degrees of hs-CRP both in asthma and intensifications of COPD and it was even perceived in the consistent articulation of COPD.12

The connection between hs-CRP levels and the seriousness of asthma has been showed up in two past examinations.13 There was a positive association just inside extreme asthmatic patients in the examination by Corlateanu An et al., 14. Considering the previous examinations, the connection between levels of hs-CRP and the seriousness of asthma shows that CRP is a proinflammatory specialist.15 Severity of asthma associates positively with the asthmatic aggravation.16 Significant differentiations in hs-CRP levels between subjects with serious asthma and controls without respiratory manifestations have as of late appeared in one examination.17 Interestingly, Takemura et al., hs-CRP levels were simply disposed in steroid-innocent patients diverged from controls.18 Also, serum hs-CRP levels in moderate asthmatic cases were altogether higher than in gentle ones in our investigation.

A huge contrast was settled between asthmatic subjects and controls similar to PFT. In any case, no critical distinction PFT and the degrees of hs-CRP of the asthmatic patients in our examination; like the previous reports by Qian et al. Clashing, there was positive association between the levels of PFT and hs-CRP according to the reports by Takemura et al. 19

Critical connections were found between inclined CRP levels and respiratory side effects like wheeze, attacks of shortness of breath after exertion and night-time cough in two examinations.20 The last investigation likewise reasoned that non- allergic asthma specifically is strongly connected with higher CRP levels, while hypersensitive asthma is not.21 Additionally, another examination showed that non-atopic asthma is immovably associated with higher hs-CRP levels, however negatively vulnerable asthma isn't.22 We didn't determinate any connection between hs-CRP and respiratory signs (p>0.05).

Conclusions

The results of this study indicated increased serum hsCRP concentration in asthma compared to controls. Increased serum hs-CRP correlates positively with severity of asthma and thus can be considered as a tool in predicting asthma status.

Acknowledgement

None.

Source of Funding

No financial support was received for the work within this manuscript.

Conflict of Interest

The authors declare they have no conflict of interest.

References

1 

Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention. Updated 2017. http://www.ginasthma.org. Accessed 19 Feb 2017. 6. Statistics Canada. Asthma Health Rep. 2005;16(2). http://publicatio ns.gc.ca/Collection-R/Statcan/82-003-XIE/0020482-003-XIE.pdf. Accessed 6 June 2017

2 

FM Ducharme SD Dell D Radhakrishnan RM Grad WTA Watson CL Yang Diagnosis and Management of Asthma in Preschoolers: A Canadian Thoracic Society and Canadian Paediatric Society Position PaperCan Respir J20152231354310.1155/2015/101572

3 

SD Aaron KL Vandemheen JM Fitzgerald M Ainslie S Gupta C Lemière Canadian Respiratory Research Network. Reevaluation of diagnosis in adults with physician-diagnosed asthmaJAMA2017317326979

4 

T Kendzerska M Sadatsafavi S D Aaron T M To M D Lougheed J M Fitzgerald Canadian Respiratory Research Network. Concurrent physician-diagnosed asthma and chronic obstructive pulmonary disease: a population study of prevalence, incidence and mortalityPLoS ONE2017123173830

5 

K Issa-El-Khoury H Kim ES Chan TV Leek F Noya CSACI position statement: systemic effect of inhaled corticosteroids on adrenal suppression in the management of pediatric asthmaAllergy Asthma Clin Immunol2015111910.1186/s13223-015-0075-z

6 

S Covantev N Mazuruc R Uzdenov A Corlateanu Spontaneous Pneumomediastinum – a Rare Asthma ComplicationFolia Med2019613472710.3897/folmed.61.e39419

7 

A Cepelis BM Brumpton LE Laugsand A Langhammer I Janszky LB Strand Asthma, asthma control and risk of ischemic stroke: The HUNT studyRespir Med2020210001310.1016/j.yrmex.2019.100013

8 

Y Raita CA Camargo MK Faridi DFM Brown YJ Shimada K Hasegawa Risk of Acute Myocardial Infarction and Ischemic Stroke in Patients with Asthma Exacerbation: A Population-Based, Self-Controlled Case Series StudyJ Allerg Clin Immunol2020811889410.1016/j.jaip.2019.06.043

9 

R Zeiger P Sullivan Y Chung JL Kreindler NM Zimmerman J Tkacz Systemic Corticosteroid-Related Complications and Costs in Adults with Persistent AsthmaJ Allerg Clin Immunol202081034556510.1016/j.jaip.2020.06.055

10 

M Cazzola P Rogliani L Calzetta MG Matera Bronchodilators in subjects with asthma-related comorbiditiesRespir Med201915143810.1016/j.rmed.2019.04.001

11 

I Tuleta D Skowasch F Aurich N Eckstein R Schueler C Pizarro Asthma is associated with atherosclerotic artery changesPlos One20171210e018682010.1371/journal.pone.0186820

12 

M Katan A Luft Global Burden of StrokeSemin Neurol201838022081110.1055/s-0038-1649503

13 

A Corlateanu S Covantev AG Mathioudakis V Botnaru M Cazzola N Siafakas Chronic Obstructive Pulmonary Disease and StrokeCOPD: J Chronic Obstr Pulm Dis20181544051310.1080/15412555.2018.1464551

14 

S Y Kim H Lim J-S Lim H G Choi Analysis of the Relationship between Adult Asthma and Stroke: A Longitudinal Follow-Up Study Using the Korean National Sample CohortBio Med Res Int2019891923010.1155/2019/8919230

15 

S Mathanraj K Balaji Praveenraj Role of hsCRP as a marker in assessing severity of asthmaIP Indian J Immunol Respir Med202052788310.18231/j.ijirm.2020.033

16 

MS Najdat AM Lutfi Evaluating the role of high-sensitivity C-reactive protein in asthmatic Iraqi patients and its correlation with parameters of patients’ clinical characteristics and pulmonary function testsAsian J Med Sci201673475310.3126/ajms.v7i3.13880

17 

M Monadi A Firouzjahi A Hosseini Serum C-reactive protein in asthma and its ability in predicting asthma control, a case-control studyCaspian J Intern Med2016713742

18 

A H Kasem High sensitivity C-Reactive protein: Its correlation with sputum cell counts in Bronchial asthmaJ Respir Med2009103187884

19 

M Monadi A Firouzjahi A Hosseini Serum C-reactive protein in asthma and its ability in predicting asthma control, a case-control studyCaspian J Intern Med2016713742

20 

T. Shimoda Y. Obase R. Kishikawa T. Iwanaga Serum high-sensitivity C-reactive protein can be an airway inflammation predictor in bronchial asthmaAllergy Asthma Proc201536223810.2500/aap.2015.36.3816

21 

S. Ahmadi-Abhari S. Kaptoge R. N. Luben N. J. Wareham K.-T. Khaw Longitudinal Association of C-Reactive Protein and Lung Function Over 13 Years: The EPIC-Norfolk StudyAm J Epidemiol20141791485610.1093/aje/kwt208

22 

M Hoshino J Ohtawa K Akitsu Increased C-reactive protein is associated with airway wall thickness in steroid-naive asthmaAnn Allergy, Asthma Immunol20141131374110.1016/j.anai.2014.04.014



jats-html.xsl


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

  • Article highlights
  • Article tables
  • Article images

Article History

Received : 13-03-2021

Accepted : 20-05-2021


View Article

PDF File   Full Text Article


Copyright permission

Get article permission for commercial use

Downlaod

PDF File   XML File   ePub File


Digital Object Identifier (DOI)

Article DOI

https://doi.org/10.18231/j.ijirm.2021.019


Article Metrics






Article Access statistics

Viewed: 1039

PDF Downloaded: 530



Medical Abbreviation List